pancreatic ductal adenocarcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.From January 1, 2018 to August 31, 2021; 2.Patients who was older than 18; 3.Patients who underwent pancreaticoduodenectomy with portal vein resection and reconstruction in Huashan Hospital; 4.Patients whose pathological type of cancer was pancreatic ductal adenocarcinoma; 5.Clinical and follow-up data were complete.
Exclusion criteria
Exclusion criteria: 1.Non-pancreatic ductal adenocarcinoma; 2.Incomplete clinical and follow-up data; 3.Patients refused to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of textbook outcome; | — |
Secondary
| Measure | Time frame |
|---|---|
| length of hospital stay;Major morbidity;Intervals between surgery and adjuvant chemotherapy;Adjuvant chemotherapy completion; | — |
Countries
China
Contacts
Huashan Hospital, Fudan University